Observational studyJournal of human hypertension2026
Trends and risk factors of hypertension in US Children and Adolescents, 1999-2023.
Observational study in Journal of human hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hypertension in Children: Narrative Review of Epidemiology, Outcome and Target Organ Damage.Children (Basel, Switzerland) · 2026Review
- The child opportunity index and its association with resting and exercising blood pressure in children: a Chicago metro area pilot study.Preventive medicine reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
We aimed to assess trends in elevated blood pressure (EBP) and hypertension among US children and adolescents before and after the COVID-19 pandemic using data from 25,916 participants aged 8-19 years in NHANES 1999-2023. Survey-weighted multinomial logistic regression was used to examine associations of sociodemographic, nutritional and other factors with EBP and hypertension overall and across subgroups during the pre-pandemic cycles (2015-2020) and post-pandemic cycles (2021-2023). Among children (n = 10,616), EBP prevalence decreased from 4.3% in 1999-2002 to 3.5% in 2021-2023 (P = 0.36), and hypertension declined from 3.3% to 2.3% (P = 0.025). Among adolescents (n = 15,300), EBP declined from 10.0% to 9.4% (P = 0.46), and hypertension prevalence fell from 8.3% to 5.1% (P < 0.001). From 2015-2023, obesity was strongly associated with both EBP and hypertension in children (odds ratio [OR] 1.78, 95% CI 1.02-3.10) and adolescents (OR 1.89, 95% CI 1.30-2.74). In children, higher dietary fat intake was associated with greater odds of EBP, and higher sodium intake with greater odds of hypertension. In adolescents, older age, male sex and non-Hispanic Black race were additional risk factors. Comparing pre-pandemic (2015-2020) with post-pandemic (2021-2023) cycles, EBP prevalence in adolescents decreased (11.6% vs 9.42%, P = 0.46) and hypertension prevalence in children changed modestly (2.53% vs 2.26%, P = 0.025). Despite concerns about pandemic-related increases in obesity, pediatric EBP and hypertension prevalence remained stable or declined from 2015 to 2023, with adiposity remaining the dominant modifiable correlate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.